OnDosis

📍 Gothenburg, Sweden🗓 Founded 2017👥 36 employees💰 Last funded Mar 2020
Pharmaceutical Manufacturing🌐 ondosis.com
Website LinkedIn
OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. We are writing a new chapter in personalized medicine, and enable closed loop disease management. OnDosis is currently developing products for individualized dosing in diseases with a significant burden on patients and healthcare such as ADHD, pain management and immunosuppression for organ transplants. Hundreds of thousands of patients with these conditions could be helped by improved dosing, ultimately leading to improving health care outcomes. OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered in Gothenburg, Sweden.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Sweden
1
Germany
1
Frequently asked questions
Who invested in OnDosis?
OnDosis has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did OnDosis last raise funding?
The most recent investment in OnDosis recorded on gritt.io was in March 2020.
When was OnDosis founded?
OnDosis was founded in 2017.
What industry is OnDosis in?
OnDosis operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is OnDosis based?
OnDosis is headquartered in Gothenburg, Sweden.